Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurons | 16 | 2023 | 1246 | 1.410 |
Why?
|
| Hippocampus | 5 | 2011 | 591 | 0.900 |
Why?
|
| Essential Tremor | 1 | 2023 | 3 | 0.830 |
Why?
|
| Tremor | 1 | 2023 | 9 | 0.830 |
Why?
|
| Nicotine | 8 | 2017 | 290 | 0.700 |
Why?
|
| Alzheimer Disease | 5 | 2013 | 971 | 0.680 |
Why?
|
| Amyloid beta-Protein Precursor | 5 | 2013 | 95 | 0.590 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2010 | 88 | 0.570 |
Why?
|
| Depression | 4 | 2019 | 837 | 0.570 |
Why?
|
| Brain | 3 | 2016 | 1449 | 0.550 |
Why?
|
| Neuropeptides | 3 | 2007 | 63 | 0.520 |
Why?
|
| Locus Coeruleus | 5 | 2011 | 15 | 0.520 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2009 | 201 | 0.510 |
Why?
|
| Presenilin-1 | 4 | 2011 | 27 | 0.510 |
Why?
|
| Astrocytes | 2 | 2016 | 244 | 0.500 |
Why?
|
| Nicotinic Agonists | 6 | 2017 | 87 | 0.480 |
Why?
|
| Hypothalamus | 3 | 2007 | 121 | 0.470 |
Why?
|
| Antidepressive Agents | 3 | 2019 | 61 | 0.470 |
Why?
|
| Copper | 1 | 2016 | 134 | 0.450 |
Why?
|
| Neuroprotective Agents | 2 | 2022 | 267 | 0.430 |
Why?
|
| Aging | 2 | 2011 | 763 | 0.430 |
Why?
|
| Disease Models, Animal | 9 | 2013 | 1554 | 0.360 |
Why?
|
| Animals | 25 | 2023 | 16694 | 0.360 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2010 | 40 | 0.330 |
Why?
|
| Parkinson Disease | 3 | 2022 | 205 | 0.310 |
Why?
|
| Mice | 12 | 2023 | 6490 | 0.310 |
Why?
|
| Estradiol | 1 | 2011 | 269 | 0.290 |
Why?
|
| Mice, Transgenic | 5 | 2011 | 658 | 0.290 |
Why?
|
| Immunohistochemistry | 5 | 2011 | 928 | 0.280 |
Why?
|
| Nerve Degeneration | 2 | 2010 | 108 | 0.270 |
Why?
|
| Sleep, REM | 1 | 2007 | 11 | 0.270 |
Why?
|
| Sleep Deprivation | 1 | 2007 | 29 | 0.260 |
Why?
|
| Ethanol | 4 | 2017 | 221 | 0.240 |
Why?
|
| Rats | 10 | 2016 | 3701 | 0.240 |
Why?
|
| Central Nervous System Depressants | 3 | 2017 | 42 | 0.230 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2005 | 25 | 0.230 |
Why?
|
| Cerebral Cortex | 4 | 2010 | 303 | 0.230 |
Why?
|
| Species Specificity | 3 | 2016 | 279 | 0.210 |
Why?
|
| Bipolar Disorder | 1 | 2005 | 83 | 0.210 |
Why?
|
| Neuroblastoma | 2 | 2022 | 134 | 0.210 |
Why?
|
| Harmaline | 1 | 2023 | 1 | 0.210 |
Why?
|
| Sulpiride | 1 | 2023 | 6 | 0.210 |
Why?
|
| Cell Count | 7 | 2014 | 140 | 0.210 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2009 | 133 | 0.200 |
Why?
|
| Rats, Inbred WKY | 3 | 2009 | 16 | 0.200 |
Why?
|
| Depressive Disorder, Major | 1 | 2005 | 128 | 0.200 |
Why?
|
| Rats, Wistar | 3 | 2009 | 282 | 0.190 |
Why?
|
| Cerebellum | 3 | 2010 | 78 | 0.180 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 138 | 0.170 |
Why?
|
| Gyrus Cinguli | 2 | 2011 | 30 | 0.170 |
Why?
|
| Male | 14 | 2016 | 22745 | 0.170 |
Why?
|
| Antiparkinson Agents | 1 | 2019 | 14 | 0.150 |
Why?
|
| Nerve Growth Factors | 1 | 2019 | 34 | 0.150 |
Why?
|
| Analysis of Variance | 4 | 2009 | 574 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 2 | 2023 | 1804 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2016 | 1737 | 0.150 |
Why?
|
| Female | 14 | 2013 | 23980 | 0.140 |
Why?
|
| Medulla Oblongata | 2 | 2010 | 40 | 0.130 |
Why?
|
| Humans | 15 | 2023 | 42113 | 0.130 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2017 | 17 | 0.130 |
Why?
|
| Neurotransmitter Agents | 1 | 2017 | 69 | 0.130 |
Why?
|
| X-Rays | 1 | 2016 | 19 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2016 | 30 | 0.120 |
Why?
|
| Fluorescence | 1 | 2016 | 113 | 0.120 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2016 | 78 | 0.120 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2016 | 82 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 214 | 0.110 |
Why?
|
| Afferent Pathways | 1 | 2014 | 43 | 0.110 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2013 | 6 | 0.100 |
Why?
|
| Presenilins | 1 | 2013 | 7 | 0.100 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 74 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2013 | 83 | 0.100 |
Why?
|
| Drug Administration Schedule | 2 | 2009 | 153 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2013 | 884 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2017 | 1111 | 0.090 |
Why?
|
| Substantia Nigra | 2 | 2010 | 49 | 0.090 |
Why?
|
| Prion Diseases | 1 | 2010 | 9 | 0.080 |
Why?
|
| Hyperkinesis | 1 | 2010 | 7 | 0.080 |
Why?
|
| Prions | 1 | 2010 | 23 | 0.080 |
Why?
|
| Neostriatum | 1 | 2010 | 28 | 0.080 |
Why?
|
| Ovariectomy | 1 | 2011 | 128 | 0.080 |
Why?
|
| Hominidae | 1 | 2010 | 12 | 0.080 |
Why?
|
| Anatomy, Comparative | 1 | 2010 | 4 | 0.080 |
Why?
|
| Gorilla gorilla | 1 | 2010 | 4 | 0.080 |
Why?
|
| Hylobates | 1 | 2010 | 3 | 0.080 |
Why?
|
| Neocortex | 1 | 2010 | 27 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2010 | 128 | 0.080 |
Why?
|
| Pan troglodytes | 1 | 2010 | 21 | 0.080 |
Why?
|
| Frontal Lobe | 1 | 2010 | 58 | 0.080 |
Why?
|
| Immobility Response, Tonic | 1 | 2009 | 1 | 0.080 |
Why?
|
| Flavonols | 1 | 2009 | 15 | 0.080 |
Why?
|
| Stereotaxic Techniques | 1 | 2009 | 19 | 0.080 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2009 | 21 | 0.080 |
Why?
|
| Macaca mulatta | 1 | 2010 | 139 | 0.080 |
Why?
|
| Gliosis | 2 | 2010 | 25 | 0.080 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2006 | 93 | 0.080 |
Why?
|
| Exploratory Behavior | 1 | 2009 | 78 | 0.080 |
Why?
|
| Swimming | 1 | 2009 | 40 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2016 | 2111 | 0.070 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 81 | 0.070 |
Why?
|
| Disease Progression | 1 | 2011 | 660 | 0.070 |
Why?
|
| Mesencephalon | 3 | 2010 | 42 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 379 | 0.070 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2008 | 11 | 0.070 |
Why?
|
| Time Factors | 2 | 2010 | 1845 | 0.070 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2022 | 81 | 0.070 |
Why?
|
| Catecholamines | 1 | 2007 | 45 | 0.070 |
Why?
|
| Phencyclidine Abuse | 1 | 2006 | 1 | 0.060 |
Why?
|
| Ventral Tegmental Area | 1 | 2007 | 47 | 0.060 |
Why?
|
| Phencyclidine | 1 | 2006 | 19 | 0.060 |
Why?
|
| Schizophrenic Psychology | 1 | 2006 | 16 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2022 | 2598 | 0.060 |
Why?
|
| Motor Activity | 1 | 2009 | 438 | 0.060 |
Why?
|
| Sarcosine | 1 | 2006 | 1 | 0.060 |
Why?
|
| Serine | 1 | 2006 | 81 | 0.060 |
Why?
|
| Dopamine | 2 | 2022 | 272 | 0.060 |
Why?
|
| Body Weight | 1 | 2007 | 428 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2006 | 156 | 0.060 |
Why?
|
| Receptors, Neuropeptide | 1 | 2004 | 6 | 0.060 |
Why?
|
| Phrenic Nerve | 1 | 2004 | 18 | 0.060 |
Why?
|
| Cell Size | 1 | 2004 | 46 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2006 | 170 | 0.050 |
Why?
|
| Respiration | 1 | 2004 | 56 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2004 | 88 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2004 | 139 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2004 | 109 | 0.050 |
Why?
|
| Cell Death | 1 | 2005 | 277 | 0.050 |
Why?
|
| Neurotoxins | 2 | 2008 | 55 | 0.050 |
Why?
|
| Aconitine | 1 | 2003 | 2 | 0.050 |
Why?
|
| Vitamin A | 1 | 2023 | 85 | 0.050 |
Why?
|
| Vitamins | 1 | 2023 | 81 | 0.050 |
Why?
|
| Mutation | 1 | 2007 | 1169 | 0.050 |
Why?
|
| Cell Survival | 2 | 2017 | 934 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2005 | 1265 | 0.040 |
Why?
|
| Cells, Cultured | 4 | 2009 | 1617 | 0.040 |
Why?
|
| Vitamin D | 1 | 2023 | 196 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 1066 | 0.040 |
Why?
|
| Behavior, Animal | 2 | 2013 | 369 | 0.040 |
Why?
|
| Functional Laterality | 2 | 2010 | 88 | 0.040 |
Why?
|
| Mecamylamine | 2 | 2013 | 21 | 0.040 |
Why?
|
| Nicotinic Antagonists | 2 | 2013 | 36 | 0.040 |
Why?
|
| MPTP Poisoning | 1 | 1997 | 12 | 0.030 |
Why?
|
| Dizocilpine Maleate | 2 | 2008 | 43 | 0.030 |
Why?
|
| Aged | 3 | 2008 | 7958 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2017 | 29 | 0.030 |
Why?
|
| Acoustic Stimulation | 2 | 2008 | 74 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 1997 | 98 | 0.030 |
Why?
|
| Apoptosis | 1 | 2005 | 1541 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2017 | 102 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 723 | 0.030 |
Why?
|
| Sclera | 1 | 2016 | 6 | 0.030 |
Why?
|
| Trabecular Meshwork | 1 | 2016 | 10 | 0.030 |
Why?
|
| Optic Nerve | 1 | 2016 | 30 | 0.030 |
Why?
|
| Aqueous Humor | 1 | 2016 | 18 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 64 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 1997 | 221 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1997 | 318 | 0.030 |
Why?
|
| Fibrosis | 1 | 2016 | 166 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2016 | 133 | 0.030 |
Why?
|
| Arousal | 2 | 2006 | 95 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 1997 | 382 | 0.030 |
Why?
|
| Middle Aged | 3 | 2008 | 11790 | 0.030 |
Why?
|
| Receptors, Nicotinic | 2 | 2008 | 114 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 487 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2014 | 82 | 0.030 |
Why?
|
| Pregnancy | 3 | 2005 | 1733 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 324 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 1997 | 170 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 85 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1997 | 1265 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 683 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 136 | 0.020 |
Why?
|
| Memory | 1 | 2013 | 175 | 0.020 |
Why?
|
| Growth and Development | 1 | 2011 | 9 | 0.020 |
Why?
|
| Primates | 1 | 2011 | 38 | 0.020 |
Why?
|
| Parvalbumins | 1 | 2010 | 17 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2010 | 48 | 0.020 |
Why?
|
| Autonomic Nervous System | 1 | 2010 | 38 | 0.020 |
Why?
|
| Choline | 1 | 2010 | 61 | 0.020 |
Why?
|
| Serotonin | 1 | 2010 | 125 | 0.020 |
Why?
|
| Kaempferols | 1 | 2009 | 4 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 52 | 0.020 |
Why?
|
| Quercetin | 1 | 2009 | 46 | 0.020 |
Why?
|
| Homeostasis | 1 | 2010 | 191 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 146 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2008 | 18 | 0.020 |
Why?
|
| Corpus Callosum | 1 | 2008 | 14 | 0.020 |
Why?
|
| Adult | 1 | 2005 | 13437 | 0.020 |
Why?
|
| Longevity | 1 | 2010 | 167 | 0.020 |
Why?
|
| Isotopes | 1 | 2008 | 9 | 0.020 |
Why?
|
| Muscarinic Agonists | 1 | 2008 | 10 | 0.020 |
Why?
|
| Bungarotoxins | 1 | 2008 | 22 | 0.020 |
Why?
|
| Pilocarpine | 1 | 2008 | 8 | 0.020 |
Why?
|
| Scopolamine | 1 | 2008 | 5 | 0.020 |
Why?
|
| Muscarinic Antagonists | 1 | 2008 | 11 | 0.020 |
Why?
|
| Computer Graphics | 1 | 1988 | 19 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 710 | 0.020 |
Why?
|
| Pyridines | 1 | 2008 | 134 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2006 | 35 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 973 | 0.020 |
Why?
|
| Electroshock | 1 | 2006 | 15 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2009 | 548 | 0.020 |
Why?
|
| Cognition | 1 | 2009 | 458 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2006 | 151 | 0.010 |
Why?
|
| Seizures | 1 | 2006 | 78 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 350 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 1076 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 148 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 686 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2005 | 226 | 0.010 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2004 | 88 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 1135 | 0.010 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 2003 | 4 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 1004 | 0.010 |
Why?
|
| Culture Media | 1 | 2003 | 96 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 64 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 2790 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 134 | 0.010 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 1997 | 59 | 0.010 |
Why?
|